• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FPC
Click for more information
0.00% 94.0¢

FAT PROPHETS GLOBAL CONTRARIAN FUND LTD - Charts / Financials

Market Cap $27.05M  ! watchlist Created with Sketch. Add to my watchlist

Fat Prophets Global Contrarian Fund Limited is a company, which provides investors with... Fat Prophets Global Contrarian Fund Limited is a company, which provides investors with access to a global portfolio. The Company’s principal activity is to invest predominantly in a concentrated portfolio of listed securities from global equity markets, with the objective of providing long-term capital growth. The Company’s investment portfolio will be managed by Fat Prophets Funds Management Pty Limited (the Manager). The investment strategy of the Company is to manage an investment portfolio across equities, commodities, currency, cash and derivatives throughout their respective market cycles with the aim of enhancing the long-term performance outcomes. The Manager’s philosophy is that markets tend to overreact to events, which presents short term overpriced or underpriced opportunities. The Company will invest in a concentrated portfolio of investments targeting the turning points of these opportunities.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 10.56am 04/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 93.0¢ 10000   1 98.5¢ 15012

Directors & Senior Management

Mr. Robert Dardano Chief Financial Officer
Mr. Angus Geddes Chief Investment Officer, Executive Director
Mr. Simon Wheatey Investment Portfolio Manager
Mr. Brett Crowley Company Secretary
Mr. Michael Gallagher Non-Executive Chairman of the Board
Ms. Katrina Vanstone Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
94.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $27.05M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 10000 93.0¢
 

Sellers (Offers)

Price($) Vol. No.
98.5¢ 15012 1
View Market Depth
Last trade - 11.37am 04/10/2024 (20 minute delay) ?

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada Shares in White Cliff Minerals (ASX:WCN) have jumped 24% as the company flags hitting copper rock chips with extremely high grades in Canada.
Neurotech knocked back by FDA as agency declares target condition not rare enough for special status Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.